[Pelotherapy of patients with diabetic poloyneuropathy: a clinical-immunological study].
Clinical presentations, stage of disease, therapeutic efficacy and parameters of humoral and cell immunity were studied in 91 patients with diabetic poloyneuropathy (DP) receiving pelotherapy. It was shown that changes both in cellular and humoral links were increased depending on DP stage. Pelotherapy led to the regress of basic objective and subjective manifestations of DP in all stages of disease. The immunocorrective effect of the treatment was revealed.